The human kidney is a progesterone-metabolizing and androgen-producing organ

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2803-2809

  Quinkler, Marcus ^a,b   Bumke Vogt, C ^a   Meyer, B ^a   Bahr V ^a   Oelkers, W ^a   Diederich, S ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDEHYDE KETONE REDUCTASE; ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; CYTOCHROME P450C17; OXIDOREDUCTASE; PRASTERONE; PREGNENOLONE; PROGESTERONE; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANDROGEN SYNTHESIS; ARTICLE; CELL ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FLUID BALANCE; HUMAN; HUMAN TISSUE; HYPERTENSION; ISOTOPE LABELING; KIDNEY CELL; KIDNEY FUNCTION; MENSTRUAL CYCLE; MOLECULAR WEIGHT; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STEROIDOGENESIS;

EID: 0038239508     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021970     Document Type: Article

References (43)

1. Rupprecht R, Reul JM, van Steensel B, Soder M, Berning B, Holsboer F, Damm K 1993 Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol 247:145-154
2. 18 substituent. Endocrinology 136:5651-5658
3. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticold receptor. Science 237:268-275
4. Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bähr V 2002 Agonistic and antagonistic properties of progesterone metabolltes at the human mineralocorticoid receptor. Eur J Endocrinol 146:789-799
5. Johansson ED, Jonasson LE 1971 Progesterone levels in anmiotic fluid and plasma from women. I. Levels during normal pregnancy. Acta Obstet Gynecol Scand 50:339-343
6. Rosenthal HE, Slaunwhite WR, Sandberg AA 1969 Transcortin: a corticosteroid-binding protein of plasma. X. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J Clin Endocrinol Metab 29:352-367
7. Quinkler M, Johanssen S, Grossmann C, Bähr V, Müller M, Oelkers W, Diederich S 1999 Progesterone metabolism in the human kidney and inhibition of 11β-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. J Clin Endocrinol Metab 84:4165-4171
8. Quinkler M, Johanssen S, Bumke-Vogt C, Oelkers W, Bähr V, Diederich S 2001 Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney. Mol Cell Endocrinol 171:21-24
9. Funder JW, Pearce PT, Smith R, Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585
10. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C 1988 Localisation of 11β-hydroxysteroid dehydrogenasetissue specific protector of the mineralocorticoid receptor. Lancet 2:986-989
11. Quinkler M, Oelkers W, Diederich S 2001 Clinical implications of glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenases in target tissues. Eur J Endocrinol 144:87-97
12. Lakshmi V, Monder C 1988 Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123:2390-2398
13. Dufort I, Rheault P, Huang X-F, Soucy P, Luu-The V 1999 Chararcteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140:568-574
14. Lin HK, Jez JM, Schlegel BP, Peehl DM, Pachter JA, Penning TM 1997 Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α/17β-HSD activity and cellular distribution. Mol Endocrinol 11:1971-1984
15. Dufort I, Labrie F, Luu-The V 2001 Human types 1 and 3 3α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. J Clin Endocrinol Metab 86:841-846
16. Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N 2001 Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171:137-149
17. 5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 317:343-347
18. Auchus RJ, Lee TC, Miller WL 1998 Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158-3165
19. Landau RL, Bergenstal DM, Lugibihl K, Kascht ME 1955 The metabolic effects of progesterone in man. J Clin Endocrinol Metab 15:1194-1215
20. Landau RL, Lugibihl K 1958 Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab 18:1237-1245
21. Wambach G, Higgins JR 1978 Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors. Endocrinology 102:1686-1693
22. Oparil S, Ehrlich EN, Lindheimer MD 1975 Effect of progesterone on renal sodium handling in man: relation to aldosterone excretion and plasma renin activity. Clin Sci Mol Med 49:139-147
23. Dunn JF, Nisula BC, Rodbard D 1981 Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53:58-68
24. Zhang Y, Dufort I, Rheault P, Luu-The V 2000 Characterization of a human 20α-hydroxysteroid dehydrogenase. J Mol Endocrinol 25:221-228
25. Nishizawa M, Nakajima T, Yasuda K, Kanzaki H, Sasaguri Y, Watanabe K, Ito S 2000 Close kinship of human 20α-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells 5:111-125
26. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K 2000 Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77
27. Luu-The V, Dufort I, Pelletier G, Labrie F 2001 Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol 171:77-82
28. Suzuki-Yamamoto T, Nishizawa M, Fukui M, Okuda-Ashitaka E, Nakajima T, Ito S, Watanabe K 1999 cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett 462:335-340
29. Miller WL, Auchus RJ, Geller DH 1997 The regulation of 17,20-lyase activity. Steroids 62:133-142
30. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI 1993 Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J Clin Endocrinol Metab 77:98-102
31. Lin D, Black SM, Nagahama Y, Miller WL 1993 Steroid 17α-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. Endocrinology 132:2498-2506
32. Auchus RJ, Miller WL 1999 Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanism and effects of mutations. Mol Endocrinol 13:1169-1182
33. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5α-reductase isoenzyme expression. J Clin Invest 92:903-910
34. MacDonald PC, Dombroski RA, Casey ML 1991 Recurrent secretion of progesterone in large amounts: an endocrine/metabolic disorder unique to young women? Endocr Rev 12:372-401
35. Concas A, Follesa P, Barbaccia ML, Purdy RH, Biggio G 1999 Physiological modulation of GABA (A) receptor plasticity by progesterone metabolites. Eur J Pharmacol 375:225-235
36. Li X, Bertics PJ, Karavolas HJ 1997 Regional distribution of cytosolic and particulate 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol 60:311-318
37. Stoffel-Wagner B 2001 Neurosteroid metabolism in the human brain. Eur J Endocrinol 145:669-679
38. Kumar D 1966 Tissue progesterone concentrations of placentas in preeclamptic patients. Am J Obstet Gynecol 95:594-595
39. Chesley LC, Tepper IH 1967 Effects of progesterone and estrogen on the sensitivity to angiotensin II. J Clin Endocrinol Metab 27:576-581
40. Brunette MG, Leclerc M 2002 Renal action of progesterone: effect on calcium reabsorption. Mol Cell Endocrinol 194:183-190
41. Reckelhoff JF, Zhang H, Srivastava K, Granger JP 1999 Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34:920-923
42. Reckelhoff JF, Granger JP 1999 Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 26:127-131
43. Reckelhoff JF, Zhang H, Granger JP 1998 Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31:435-439